Vg Life Sciences Stock Performance
The entity owns a Beta (Systematic Risk) of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Vg Life are completely uncorrelated.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vg Life Sciences are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak essential indicators, Vg Life unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
VGLS |
Vg Life Relative Risk vs. Return Landscape
If you would invest 0.01 in Vg Life Sciences on November 3, 2025 and sell it today you would lose (0.01) from holding Vg Life Sciences or give up 100.0% of portfolio value over 90 days. Vg Life Sciences is currently generating 56.4516% in daily expected returns and assumes 251.3054% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than VGLS, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vg Life Target Price Odds to finish over Current Price
The tendency of VGLS Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.00 | 90 days | 0.00 | close to 99 |
Based on a normal probability distribution, the odds of Vg Life to move above the current price in 90 days from now is close to 99 (This Vg Life Sciences probability density function shows the probability of VGLS Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Vg Life has the beta coefficient that is very close to zero. This entails the returns on DOW JONES INDUSTRIAL and Vg Life do not appear to be related. Additionally It does not look like Vg Life's alpha can have any bearing on the current valuation. Vg Life Price Density |
| Price |
Predictive Modules for Vg Life
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vg Life Sciences. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Vg Life Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vg Life is not an exception. The market had few large corrections towards the Vg Life's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vg Life Sciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vg Life within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.00 | |
β | Beta against Dow Jones | 0.00 | |
σ | Overall volatility | 0.000031 | |
Ir | Information ratio | 0.00 |
Vg Life Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vg Life for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vg Life Sciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vg Life Sciences is way too risky over 90 days horizon | |
| Vg Life Sciences has some characteristics of a very speculative penny stock | |
| Vg Life Sciences appears to be risky and price may revert if volatility continues | |
| Vg Life Sciences currently holds 3.38 M in liabilities. Vg Life Sciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vg Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vg Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vg Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VGLS to invest in growth at high rates of return. When we think about Vg Life's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vg Life Sciences currently holds about 22.92 K in cash with (1.91 M) of positive cash flow from operations. |
Vg Life Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of VGLS Pink Sheet often depends not only on the future outlook of the current and potential Vg Life's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vg Life's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 27.6 M | |
| Cash And Short Term Investments | 34 K |
Vg Life Fundamentals Growth
VGLS Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vg Life, and Vg Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VGLS Pink Sheet performance.
| Return On Asset | -1.51 | |||
| Current Valuation | 4.44 M | |||
| Shares Outstanding | 107.88 M | |||
| Price To Earning | (0.14) X | |||
| Price To Book | 32.38 X | |||
| EBITDA | (3.43 M) | |||
| Cash And Equivalents | 22.92 K | |||
| Total Debt | 3.38 M | |||
| Book Value Per Share | (0.05) X | |||
| Cash Flow From Operations | (1.91 M) | |||
| Earnings Per Share | (0.07) X | |||
| Total Asset | 1.32 M | |||
| Retained Earnings | (109.84 M) | |||
| Current Asset | 40 K | |||
| Current Liabilities | 5.46 M | |||
About Vg Life Performance
Assessing Vg Life's fundamental ratios provides investors with valuable insights into Vg Life's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Vg Life is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
VG Life Sciences Inc., a biotechnology company, researches and develops a pipeline of transformative therapies for combat cancer, infectious diseases, and autoimmune diseases caused by chronic inflammation. VG Life Sciences Inc. operates as a subsidiary of Feelux Co., Ltd. VG Life operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.Things to note about Vg Life Sciences performance evaluation
Checking the ongoing alerts about Vg Life for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vg Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vg Life Sciences is way too risky over 90 days horizon | |
| Vg Life Sciences has some characteristics of a very speculative penny stock | |
| Vg Life Sciences appears to be risky and price may revert if volatility continues | |
| Vg Life Sciences currently holds 3.38 M in liabilities. Vg Life Sciences has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Vg Life until it has trouble settling it off, either with new capital or with free cash flow. So, Vg Life's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Vg Life Sciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VGLS to invest in growth at high rates of return. When we think about Vg Life's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (6.19 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Vg Life Sciences currently holds about 22.92 K in cash with (1.91 M) of positive cash flow from operations. |
- Analyzing Vg Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vg Life's stock is overvalued or undervalued compared to its peers.
- Examining Vg Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vg Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vg Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vg Life's pink sheet. These opinions can provide insight into Vg Life's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for VGLS Pink Sheet Analysis
When running Vg Life's price analysis, check to measure Vg Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vg Life is operating at the current time. Most of Vg Life's value examination focuses on studying past and present price action to predict the probability of Vg Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vg Life's price. Additionally, you may evaluate how the addition of Vg Life to your portfolios can decrease your overall portfolio volatility.